1 asmically expressing aequorin were generated
to test this possibility.
2 ologue of the Huntington's disease (HD) gene
to test this possibility.
3 nefit, but further studies would be required
to test this possibility.
4 , Ganbulanyi) but these are too poorly known
to test this possibility.
5 lie SITBs, but additional research is needed
to test this possibility.
6 , and experiments were therefore carried out
to test this possibility.
7 To test this possibility,
115 healthy participants aged
8 To test this possibility,
44 male offenders and 46 nonof
9 To test this possibility,
a DeltafixK mutant of R. palus
10 To test this possibility,
a small molecule was isolated
11 To test this possibility,
amino acids at positions 207 a
12 To test this possibility and the contribution of MBNLs t
13 To test this possibility and to characterize the role of
14 To test this possibility and to uncover AbetaPP-binding
15 ploited therapeutically, and clinical trials
to test this possibility are already being planned.
16 To test this possibility,
bone marrow (BM) and fetal liv
17 To test this possibility,
both the cell membranes and th
18 To test this possibility,
CD2/F(1) mice were placed on s
19 To test this possibility,
chimeric proteins were constru
20 To test this possibility,
clones of MG-63 cells, a human
21 To test this possibility directly, cells of the coelomic
22 As a model system
to test this possibility,
fluorescence resonance energy
23 To test this possibility for body weight, mice with sele
24 To test this possibility,
full-length type I or type III
25 To test this possibility further, we analyzed the mutant
26 To test this possibility,
H19-7 cells were transfected o
27 a UPEC virulence factor, few in vivo studies
to test this possibility have been reported.
28 To test this possibility healthy young Balb/c male mice
29 To test this possibility,
here we employed Monte Carlo-b
30 Clinical trials
to test this possibility,
however, have yielded disappoi
31 To test this possibility,
in the present study, we have
32 To test this possibility,
in vitro experiments were cond
33 To test this possibility,
it was shown that only minor a
34 To test this possibility,
K5-Cre transgenic mice were cr
35 To test this possibility,
leukocytes from black LJP pati
36 To test this possibility,
mice were injected intravenous
37 To test this possibility,
mouse cardiac allograft recipi
38 To test this possibility,
mutagenesis of residues on bot
39 To test this possibility,
new sources of FGF8 were intro
40 To test this possibility of direct measurements in blood
41 To test this possibility,
participants underwent functio
42 To test this possibility physiologically, we used two-ph
43 To test this possibility,
primary cultures of cells from
44 To test this possibility,
rat hippocampal tissue was inc
45 To test this possibility rats were adrenalectomized or g
46 To test this possibility,
rats were trained with a physi
47 To test this possibility,
rhesus monkeys with rhinal cor
48 To test this possibility,
Sf9 cell membranes expressing
49 To test this possibility,
site-directed mutations by ala
50 To test this possibility stereological electron microsco
51 To test this possibility,
the alanine in GluR1 was conve
52 To test this possibility,
the angular motion of LC1 and
53 To test this possibility,
the effect of BAFF neutralizat
54 To test this possibility,
the effects of in vitro and in
55 To test this possibility,
the entire coding region of th
56 To test this possibility,
the immune systems of adult mi
57 To test this possibility,
the methylation status of a cl
58 To test this possibility,
transgenic mice expressing hum
59 To test this possibility,
transgenic mice were generated
60 To test this possibility,
transgenic mice were generated
61 To test this possibility,
TRPV1-cre mice were used to re
62 To test this possibility,
unilateral, two-stage (progres
63 To test this possibility we contrasted the phenotype of
64 To test this possibility we enumerate putative domain bo
65 To test this possibility we examined the degree to which
66 To test this possibility we examined the progression of
67 To test this possibility we introduced the 5'-UTR of mou
68 To test this possibility we rotated three to four segmen
69 To test this possibility,
we administered the anti-CD20
70 To test this possibility,
we characterized mice in which
71 To test this possibility,
we compared isometric force, l
72 To test this possibility,
we compared the performance of
73 To test this possibility,
we compared the performance of
74 To test this possibility,
we conditioned rats to fear tw
75 To test this possibility,
we created a null mutation of
76 To test this possibility,
we created transgenic mice tha
77 To test this possibility,
we designed a mutant Galpha th
78 To test this possibility,
we designed a series of experi
79 To test this possibility,
we determined the entire codin
80 To test this possibility,
we developed a coculture micro
81 To test this possibility,
we disrupted exon 11 of MOR-1,
82 To test this possibility,
we employed alanine scanning m
83 To test this possibility,
we employed N-ethylmaleimide (
84 To test this possibility,
we employed site-directed muta
85 To test this possibility,
we engineered a peptide with a
86 To test this possibility,
we established an in vivo aner
87 To test this possibility,
we established primary HER2(+)
88 To test this possibility,
we estimated the crossover rat
89 To test this possibility,
we evaluated AgRP mRNA and pro
90 To test this possibility,
we evaluated the expression of
91 To test this possibility,
we examined fluorescence reson
92 To test this possibility,
we examined renal fibrosis ind
93 To test this possibility,
we examined the alteration of
94 To test this possibility,
we examined the contamination
95 To test this possibility,
we examined the effect of EGFR
96 To test this possibility,
we examined the expression and
97 To test this possibility,
we examined the expression of
98 To test this possibility,
we exposed 16-week-old female
99 To test this possibility,
we expressed in mouse eggs a c
100 To test this possibility,
we first determined that Abcb1
101 To test this possibility,
we fixed the tissue by perfusi
102 To test this possibility,
we fused Gal4DB directly to ei
103 To test this possibility,
we generated a new NOD stock d
104 To test this possibility,
we generated a panel of reasso
105 To test this possibility,
we generated a series of MDM2/
106 To test this possibility,
we generated anti-p53 CD4(+) T
107 To test this possibility,
we generated conditional knock
108 To test this possibility,
we generated human cell line a
109 To test this possibility,
we generated mice having 182%
110 To test this possibility,
we generated recombinant HIV-1
111 To test this possibility,
we generated site-specific mut
112 To test this possibility,
we have created conditional HD
113 To test this possibility,
we have deleted the MAR from a
114 To test this possibility,
we have extended our previous
115 To test this possibility,
we have generated transgenic m
116 To test this possibility,
we have measured the nonenzyma
117 To test this possibility,
we have quantitatively analyse
118 To test this possibility,
we have used mouse models to c
119 To test this possibility,
we have used purified recombin
120 To test this possibility,
we have used RNA interference
121 To test this possibility,
we implemented a streamlined a
122 To test this possibility,
we induced persistent hyperten
123 To test this possibility,
we infected bone marrow-derive
124 To test this possibility,
we initially looked for a cis-
125 To test this possibility,
we injected the highly sensiti
126 To test this possibility,
we integrated pharmacology usi
127 To test this possibility,
we introduced point mutations
128 To test this possibility,
we investigated changes in int
129 To test this possibility,
we investigated effects of a G
130 To test this possibility,
we investigated Granger-causal
131 To test this possibility,
we investigated the hepatic re
132 To test this possibility,
we investigated the interactio
133 To test this possibility,
we looked for morphologically
134 To test this possibility,
we measured the levels of PGE2
135 To test this possibility,
we measured the variability of
136 To test this possibility,
we monitored shelterin binding
137 To test this possibility,
we performed protein interacti
138 Here,
to test this possibility,
we performed two-photon imagin
139 To test this possibility,
we rationally engineered QUAD
140 To test this possibility,
we reconstituted the activity
141 To test this possibility,
we recorded from GCs of med (N
142 To test this possibility,
we recorded light-evoked Ca(2+
143 To test this possibility,
we sought to characterize the
144 To test this possibility,
we stimulated cell proliferati
145 To test this possibility,
we systematically aggregated s
146 To test this possibility,
we trained rhesus monkeys on d
147 To test this possibility,
we treated four macaques with
148 To test this possibility,
we use analysis and simulation
149 To test this possibility,
we used a gene targeting appro
150 To test this possibility,
we used a mouse model (mice fe
151 To test this possibility,
we used a perceptually ambiguo
152 To test this possibility,
we used a task in which rats,
153 To test this possibility,
we used an attentional capture
154 To test this possibility,
we used biochemical and comput
155 To test this possibility,
we used mAb injection to deple
156 As a first step
to test this possibility,
we used pharmacological inhibi
157 To test this possibility,
we used signal processing to e
158 To test this possibility,
we used simulations in a compu
159 To test this possibility,
we utilized a full allogeneic
160 To test this possibility,
we utilized an adenovirus vect